✦ LIBER ✦

Quality assurance of the EORTC trial 22881/10882: Boost versus no boost in breast conserving therapy

✍ Scribed by G. van Tienhoven; B. J. Mijnheer; H. Bartelink; D. G. González

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nomogram to predict ipsilateral breast r

✍ Erik van Werkhoven; Guus Hart; Harm van Tinteren; Paula Elkhuizen; Laurence Coll 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 315 KB

274Is a boost dose essential in breast c

✍ H. Bartelink; E. van der Schueren; H.P. Hamers; H. Struikmans; M. van Glabbeke; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Predictors of the risk of fibrosis at 10

✍ Sandra Collette; Laurence Collette; Tom Budiharto; Jean-Claude Horiot; Philip M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 579 KB

Predictors of the risk of fibrosis at 10

✍ DeFoe, S.G.; Jones, H.A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

The addition of a boost dose on the prim

✍ P.M. Poortmans; L. Collette; H. Bartelink; H. Struikmans; W.F. Van den Bogaert; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 225 KB

Impact of a Higher Radiation Dose on Loc

✍ Freedman, G.M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB